- Home
- CHRO
as 12-18-2024 9:47am EST
Stocks
Channel Therapeutics Corp is a clinical-stage biotechnology company developing and commercializing novel, non-opioid, non-addictive therapeutics to alleviate pain. The initial clinical focus is to selectively target the sodium ion channel known as NaV1.7 for the treatment of various types of chronic pain, acute and chronic eye pain, and post-surgical nerve blocks. Its pipeline includes CC8464 for ISFN and EM and CT2000 for Acute and CHronic Eye Pain-Dry Eye Disease.
| Founded: | 2002 | Country: | United States |
| Employees: | N/A | City: | NORTH BRUNSWICK |
| Market Cap: | 4.2M | IPO Year: | 2024 |
| Target Price: | N/A | AVG Volume (30 days): | 121.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.20 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.45 - $6.00 | Next Earning Date: | 11-13-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Chromocell Therapeutics Corporation News
CHRO Breaking Stock News: Dive into CHRO Ticker-Specific Updates for Smart Investing
GlobeNewswire
a month ago
Chromocell Announces Name Change to “Channel Therapeutics Corporation” and Provides Therapeutic Program Updates
GlobeNewswire
2 months ago
Chromocell Announces Unveiling of Injectable Depot Program for the Treatment of Surgical Pain
GlobeNewswire
2 months ago
Chromocell to Present at Upcoming Fall Investor Conferences
GlobeNewswire
2 months ago
Chromocell Announces Amendment to Stock Repurchase Plan
GlobeNewswire
3 months ago
Life Sciences Virtual Investor Forum Presentations Now Available for Online Viewing
GlobeNewswire
3 months ago
Life Sciences Virtual Investor Forum Agenda Announced for September 19th
GlobeNewswire
3 months ago
Chromocell to Participate in Life Sciences Investor Forum September 19th
GlobeNewswire
3 months ago
Chromocell to Present at the H.C. Wainwright 26th Annual Global Investment Conference
Compare CHRO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CHRO Chromocell Therapeutics Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.